source
- Amgen’s Repatha linked to fewer heart attacks while Novartis reports seven new tumor cases in Zolgensma patientsAmgen reported that its cholesterol‑lowering drug Repatha was associated with a lower incidence of heart attacks in a recent analysis. The data suggest the therapy may provide cardiovascular benefi…
- Podcast examines Democrats' midterm win and concerns over a costly, questionable fertility genetic procedureStat's weekly biotech podcast "The Readout LOUD" released an episode featuring Washington correspondent Daniel Payne to discuss how the Democrats' sweeping midterm victory could shape drug pricing…